Regulation of Pharmaceutical Innovation: The 1962 Amendments (Evaluative Studies 15) (Evaluative studies, 15) (Paperback)

by Sam Peltzman (Author), Yale Brozen (Foreword)

Product Details

• Paperback: 118 pages
• Publisher: American Enterprise Institute for Public Policy Research (1974)
• Language: English
• ISBN-10: 0844731285
• ISBN-13: 978-0844731285
• Average Customer Review: 5.0 out of 5 stars See all reviews (1 customer review)
• Amazon.com Sales Rank: #3,963,513 in Books (See Bestsellers in Books)

Customer Reviews

Most Helpful Customer Reviews

1 of 2 people found the following review helpful:

5.0 out of 5 stars The Effects of Regulation, November 8, 2005

By	cortezhill (San Diego, CA) - See all my reviews (TOP 1000 REVIEWER)

Regulation of Pharmaceutical Innovation: The 1962 Amendments by Sam Peltzman concludes that the 1962 ("proof of efficacy") amendments to the Food, Drug and Cosmetic Act of 1938 (1) have cut the number of new drugs (new chemical entities) brought to the market each year by half with no corresponding reduction in inefficacious drugs, (2) have doubled the costs of drug development, (3) have have increased drug prices by reducing competition among drugs (so that the sick pay $50 million more each year for drugs), and (4) have imposed substantial net social costs from death and illnesses that could have been prevented if the development of new drugs had not been hampered by the amendments. These conclusions are reached dispite the fact that Professor Peltzman has assumed for the amendments benefits that cannot be proven and may not have taken place. -- from book's back cover